Kamunting Street Capital Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Kamunting Street Capital Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,667	Closed	-$110K	–	69
2019 Q4	$110K	Hold	2,667	–	–	0.07%	57
2019 Q3	$38K	Hold	2,667	–	–	0.03%	37
2019 Q2	$94K	Hold	2,667	–	–	0.09%	46
2019 Q1	$150K	Hold	2,667	–	–	0.18%	33
2018 Q4	$128K	Hold	2,667	–	–	0.12%	33
2018 Q3	$194K	Hold	2,667	–	–	0.18%	22
2018 Q2	$220K	Buy	2,667 +1,023	+62%	+$98.8K	0.3%	20
2018 Q1	$173K	Hold	1,644	–	–	0.14%	30
2017 Q4	$211K	Buy	1,644 +644	+64%	+$79.2K	0.15%	33
2017 Q3	$116K	Buy	+1,000	New	+$120K	0.07%	36

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FMBTD

First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Kamunting Street Capital Management's VBIV Position: Q1 2020 in Review

Kamunting Street Capital Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2020, closing a stake of 2,667 shares — an estimated $110K sold.

Kamunting Street Capital Management first reported a position in VBIV in Q3 2017 and held it in 10 quarters. The position peaked at $220K in Q2 2018. 71 funds tracked by Wall St. Rank hold VBIV as of Q1 2020.

Kamunting Street Capital Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2020 after selling out during the quarter.
Kamunting Street Capital Management sold 2,667 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2020, an estimated $110K.
Kamunting Street Capital Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2017 and held it in 10 quarters.
Kamunting Street Capital Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $220K in Q2 2018.
71 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2020.

Based on Kamunting Street Capital Management's 13F filing for Q1 2020, filed 15 May 2020.